The Chan Zuckerberg Initiative (CZI) is undergoing significant transformation at the start of 2026, signaling a shift in focus towards AI-powered biomedical research. This realignment is accompanied by the decision to lay off approximately 70 employees, which constitutes about 8% of the organization’s workforce. The job cuts, primarily affecting the headquarters in Redwood City, California, were confirmed by a spokesperson and come as part of a broader strategy to recalibrate the organization’s mission.
In 2025, co-founders Mark Zuckerberg and Dr. Priscilla Chan laid the groundwork for a transition aimed at enhancing the initiative’s impact on biomedical research, particularly through its Biohub network. This evolution marks a retreat from earlier efforts focused on education and social justice, although the couple plans to continue supporting local organizations.
Zuckerberg emphasized the significance of the Biohub model during a November event at the Biohub Imaging Institute, stating, “I feel like the science work that we’ve done… has been the most impactful thing that we have done.” The couple is committed, through the Giving Pledge, to donating 99% of their wealth, reinforcing their focus on scientific endeavors.
This pivot towards a more science-centric focus aligns CZI with other major philanthropic organizations, such as the Gates Foundation, which similarly emphasizes funding for healthcare and disease research. The Gates Foundation has announced plans to make a record $9 billion in donations this year, underlining a trend among major donors to prioritize science and technology-driven initiatives.
The layoffs at CZI are intended to redirect resources toward Biohub, an expanding network of nonprofit biomedical research institutes aiming to address the challenge of diseases. While some employees were reallocated to different teams, the organization now seeks to enhance its capacity with additional experts in research-heavy roles, leading to the necessity of layoffs.
Affected employees received a 60-day notice and are to be compensated with severance packages that include 16 weeks of base pay, health insurance, and a $10,000 stipend for added support.
Since the inception of Biohub in 2016, Zuckerberg and Chan have pledged $4 billion to basic science research and anticipate this figure will double over the next decade. CZI operates with an annual budget of approximately $1 billion, emphasizing its commitment to advancing biomedical science and technology.
Both CZI and Meta, Zuckerberg’s technology company, are heavily investing in artificial intelligence. Meta has committed to spending between $115 billion and $135 billion on developing advanced AI capabilities for various applications, reflecting a shared vision of transforming their respective fields through technology.
In their November blog post, the couple articulated their belief that “accelerating science is the most positive impact we think we can make,” indicating that the future direction of both CZI and Meta will be increasingly intertwined with AI research and applications. This strategic focus positions CZI to tackle some of humanity’s most pressing health challenges as it embarks on this new chapter in its philanthropic journey.
